pathology
Shez Partovi, chief innovation and strategy officer at Philips, discussed the helium-free BlueSeal MRI and AI advances in a sit down with MobiHealthNews at JPM.
It plans to secure more regulatory approvals for its AI pathology platform.
The five-year deal will utilize PathAI's algorithms for translational research and clinical diagnostics.
It is also partnering with Sonic Healthcare to develop new pathology AI tools.
The firm will provide its AI-powered platform to Kantonsspital Baselland.
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
Numan plans to continue its expansion organically and through further M&A activity.
Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders.
The Series A round comes just half a year after the Columbus, Ohio-based startup's prior fundraise.